[rev_slider alias="mainsite"][/rev_slider]

Cheaper

Up to 80% cost
savings

Efficient

Fewer steps than
traditional ELISA

Smaller

Need only 20 µL of sample and reagents

Faster

5X shorter assay time - see detailed comparison

Competitive

Equal or better sensitivity and dynamic range

Cheaper

Up to 80% cost savings

Smaller

Need only 20 µL of sample and reagents

Efficient

Fewer steps than traditional ELISA

Faster

5X shorter assay time - see detailed comparison

Cheaper

Up to 80% cost savings

Cheaper

Up to 80% cost
savings

Efficient

Fewer steps than traditional
ELISA

Smaller

Need only 20 µL of sample and reagents

Faster

5X shorter assay time - see detailed comparison

Competitive

Equal or better sensitivity and dynamic range

about-left-final

ABOUT US
About Optofluidic Bioassay

Optofluidic Bioassay was formed to further develop and bring to market its proprietary, disposable microfluidic 96-well plate, which significantly improves the conventional ELISA test workflow.

Our new technology improves the ELISA assay process in every way to allow for more efficient testing. It will be completed faster while requiring less material to test.

Please continue reading to learn more about how our product can help your studies.

Why Choose Us

Problem Statement and Opportunity

ELISA(Enzyme-linked ImmunosorbentAssay) widely used diagnostics:

Immunology, cancer, infectious diseases, inflammation, neuroscience, protein quantification, for example for cardiac, liver and kidney disease, etc.

Major pain points, from customer discovery:

  • Increase sensitivity
  • Reduce reagent usage (reagents are 80% of cost)
  • Reduce assay time and Increase throughput

Need for fast and accurate point-of-care diagnosis

  • Urgent care centers, cardiologists, liver and kidney disease specialists
  • Reduce unnecessary emergency room transfers
  • Disease management and treatment response monitoring
  • Minimum $4.4B annual opportunity

Desire for fast and accurate personal diagnostics

  • Provide early warning signs to chronic disease patients or those with family history
  • Focus on prevention and early intervention
  • $5B global home diagnostic market

Our technology not only significantly decreases the total assay time, but also significantly reduces the sample size and reagent consumption to do so.

Our New Plate

We developed a disposable microfluidic 96-well plates that significantly reduces assay time and sample/regent consumption while achieving the same or better sensitivity and dynamic range in comparison with the traditional 96-well plate. Our plate is currently designed for both fluorescence-based and chemiluminescence-based ELISA measurement. For details of the technology, please see here. Please contact us for free trials.

left-plate

READY TO HELP

Get The Right Labtechnician Care Book With Your Doctor

Error: Contact form not found.

OUR NEWS

Publish What You Think